Ramdeny, S., Chaudhary, A., Worth, A., Ghorashian, S., Slatter, M., Lum, S. H., & Vora, A. (2021). Activity of blinatumomab in lymphoblastic leukemia with impaired T-cell immunity due to congenital immunodeficiency. Blood Adv.
Chicago Style CitationRamdeny, Sandheeah, Asima Chaudhary, Austen Worth, Sara Ghorashian, Mary Slatter, Su Han Lum, and Ajay Vora. "Activity of Blinatumomab in Lymphoblastic Leukemia With Impaired T-cell Immunity Due to Congenital Immunodeficiency." Blood Adv 2021.
MLA CitationRamdeny, Sandheeah, et al. "Activity of Blinatumomab in Lymphoblastic Leukemia With Impaired T-cell Immunity Due to Congenital Immunodeficiency." Blood Adv 2021.
Warning: These citations may not always be 100% accurate.